NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 193 filers reported holding NOVAVAX INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,204,000 | -31.7% | 12,066,999 | +12.7% | 0.00% | -40.0% |
Q3 2016 | $22,266,000 | -69.8% | 10,704,775 | +5.4% | 0.01% | -68.8% |
Q2 2016 | $73,829,000 | +41.1% | 10,155,357 | +0.1% | 0.02% | +33.3% |
Q1 2016 | $52,340,000 | -37.5% | 10,143,371 | +1.7% | 0.01% | -36.8% |
Q4 2015 | $83,717,000 | +13.4% | 9,978,226 | -4.4% | 0.02% | 0.0% |
Q3 2015 | $73,796,000 | -33.3% | 10,437,968 | +5.1% | 0.02% | -29.6% |
Q2 2015 | $110,597,000 | +46.7% | 9,927,933 | +8.9% | 0.03% | +50.0% |
Q1 2015 | $75,403,000 | +42.7% | 9,117,614 | +2.3% | 0.02% | +38.5% |
Q4 2014 | $52,850,000 | +57.6% | 8,912,279 | +10.8% | 0.01% | +44.4% |
Q3 2014 | $33,541,000 | +2.4% | 8,043,390 | +13.5% | 0.01% | 0.0% |
Q2 2014 | $32,752,000 | -6.9% | 7,089,127 | -8.7% | 0.01% | -10.0% |
Q1 2014 | $35,168,000 | -8.0% | 7,763,431 | +4.0% | 0.01% | -16.7% |
Q4 2013 | $38,209,000 | +115.1% | 7,462,694 | +32.3% | 0.01% | +100.0% |
Q3 2013 | $17,764,000 | +81.5% | 5,639,238 | +18.1% | 0.01% | +50.0% |
Q2 2013 | $9,790,000 | – | 4,775,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |